Despite decades of tobacco control measures, smoking continues to impose a heavy health burden on Pakistan. What has shifted in recent years is the scale of an unintended consequence: the rapid expansion of the illicit cigarette market. Estimates cited by tax authorities and independent analysts suggest that illegal cigarettes may now account for more than half of all sales, raising questions about whether existing policies are achieving their intended public health outcomes.
Higher taxes, stricter enforcement, and repeated crackdowns have long formed the backbone of Pakistan’s tobacco control strategy. Yet smoking-related disease remains a major contributor to non-communicable illness, while unregulated cigarettes, often cheaper and produced outside regulatory oversight, have become increasingly accessible. For public health observers, this paradox raises a familiar concern: when policy success is measured primarily by restrictions, behaviour can shift rather than disappear.
Globally, this tension is not unique. The World Health Organization (WHO) has noted that although smoking prevalence has declined in parts of the world, progress has slowed or plateaued in many low- and middle-income countries. With close to one billion people worldwide still smoking, policymakers continue to debate whether existing tools are reducing harm at the pace required.
At the centre of this debate is a scientific distinction that is sometimes overlooked. Much of the disease burden associated with smoking stems from the toxic chemicals generated when tobacco is burned. Combustion produces thousands of compounds, many of them carcinogenic. Nicotine is addictive and not risk-free, but it is the process of burning tobacco that creates the majority of the substances most strongly linked to cancer, cardiovascular disease, and lung damage.
This distinction matters for regulation. When policy frameworks focus solely on deterrence without accounting for how harm is produced, they may fail to influence actual exposure patterns. Pakistan’s expanding illicit cigarette trade suggests that enforcement-heavy approaches can, under certain conditions, displace demand into unregulated channels, undermining both public health oversight and state revenue.
So far, the national conversation has centred largely on compliance, taxation, and punishment. These tools remain important. But as illicit supply grows and disease burden persists, a broader evaluation may be warranted. The question is not whether tobacco control policies are well-intentioned. It is whether they are being measured against outcomes that reflect real-world behaviour.
In a landscape where illegal products are filling market gaps and smoking-related disease remains high, Pakistan may need to reassess how it defines success. Not by relaxing controls, but by ensuring that policy design aligns with both scientific evidence and behavioural realities.